Physician profile
Juan Abril
NPI 1144421934
$13,099.59
in general payments reported to CMS, 2019-2025
48 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,317 · 2020: $907 · 2021: $1,967 · 2022: $2,489 · 2023: $3,477 · 2024: $2,806 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,203 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,203.36 |
| Education | $216.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,413.59 | 2019-2024 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,889.80 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Genzyme Corporation | $1,159.59 | 2019-2024 | |
| Insmed, INC. | $942.24 | 2019-2024 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $575.11 | 2019-2024 | Ofev |
| Genentech USA, INC. | $459.55 | 2019-2022 | |
| Inspire Medical Systems, INC. | $432.52 | 2023-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $428.53 | 2019-2024 | Opsumit, Uptravi |
| United Therapeutics Corporation | $338.16 | 2019-2024 | Tyvaso |
| Amgen INC. | $330.60 | 2022-2024 | Tezspire |
| Grifols USA, LLC | $303.78 | 2021-2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $285.78 | 2019-2024 | Yupelri |
| Electromed, INC. | $239.46 | 2019-2024 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $233.94 | 2019-2024 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $233.31 | 2019-2024 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $165.26 | 2020-2023 | Acthar |
| Sunovion Pharmaceuticals INC. | $154.53 | 2019-2020 | |
| Philips North America LLC | $140.54 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $137.98 | 2023-2024 | |
| Mallinckrodt Enterprises LLC | $125.98 | 2019 | |
| Harmony Biosciences LLC | $91.26 | 2020-2024 | |
| Inogen, INC. | $90.28 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merck Sharp & Dohme LLC | $86.90 | 2019-2023 | |
| Vapotherm INC | $70.35 | 2021-2022 | |
| Baxter Healthcare | $65.49 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $58.85 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $57.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $56.61 | 2019-2023 | Airduo Digihaler |
| Shionogi INC | $52.21 | 2024 | Fetroja |
| Advanced Respiratory, INC | $50.54 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.61 | 2019-2020 | |
| Pulmonx Corporation | $34.25 | 2022-2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Ani Pharmaceuticals, INC. | $32.60 | 2024 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $32.07 | 2023 | Sunosi |
| Monaghan Medical Corporation | $28.91 | 2024 | Aerobika |
| Takeda Pharmaceuticals U.S.A., INC. | $27.97 | 2020 | |
| Lilly USA, LLC | $24.90 | 2022 | |
| Astellas Pharma US INC | $24.05 | 2021 | |
| Sanofi Pasteur INC. | $23.31 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $22.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $21.75 | 2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $19.76 | 2023 | Ultomiris |
| Gilead Sciences, INC. | $17.47 | 2019 | |
| Amarin Pharma, INC. | $17.31 | 2020 | |
| Novo Nordisk INC | $16.67 | 2023 | Rybelsus, Ozempic |
| Circassia INC. | $15.44 | 2019 | |
| Hikma Pharmaceuticals USA | $14.99 | 2024 | Ryaltris |
| E.R. Squibb & Sons, L.L.C. | $14.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Abril listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.